Search Medical Condition
Please enter condition
Please choose location

Johnston, Rhode Island Clinical Trials

A listing of Johnston, Rhode Island clinical trials actively recruiting patient volunteers.

RESULTS

Found (186) clinical trials

A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

The study consists of Screening Phase(4 weeks before administration of study drug),Active Treatment Phase(Week 0-Week 44),Follow Up Phase(Week 44-Week 56).During various study periods,safety assessments(example[e.g] recording of adverse events,Vital signs,Tuberculosis evaluation,Chest radiograph,Urine pregnancy Test);Efficacy assessments(e.g IGA,PASI);Clinical Laboratory Assessments(e.g haematology,chemistry);Biomarkers/Genetic evaluations,will be performed per the study procedures.The primary hypotheses are that guselkumab ...

Phase

0.36 miles

Learn More »

BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis

Randomized, Double-Blind, Placebo-Controlled, Multiple-Site, Parallel Design, Bioequivalence with Clinical Endpoints.

Phase

0.36 miles

Learn More »

A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

This is a randomized, multicenter, double-blind, vehicle-controlled, 2 arm study to evaluate the safety and efficacy of FMX103 topical foam containing 1.5% minocycline compared to vehicle, in the treatment of subjects with moderate-to-severe facial papulopustular rosacea. Qualified subjects will be randomized to receive 1 of the following 2 treatments: - ...

Phase

0.36 miles

Learn More »

A Study in Subjects With Moderate Atopic Dermatitis

The main objectives of this study are to: - Evaluate the safety and tolerability of ALX-101 Gel 1.5% and 5% when applied topically in subjects with moderate atopic dermatitis compared with a matching ALX-101 Gel Vehicle - Evaluate the dose-response relationship of ALX-101 Gel 1.5% and 5% when applied topically ...

Phase

0.36 miles

Learn More »

If you have been diagnosed with acne, and are 12 years old or older, you may qualify to participate in a research study to evaluate an investigational medication for acne. Study participants will receive: Study Medications Study related testing Physical exams at no cost Compensation for time and travel For ...

Phase N/A

0.36 miles

Learn More »

If you have been diagnosed with chronic plaque-type psoriasis and are between18 and 70 years old, you may qualify to participate in a research study to evaluate and investigational medication for the treatment of plaque psoriasis. Qualified Study Participants will receive: Study Medications Study related testing Physical exams at no ...

Phase N/A

0.36 miles

Learn More »

Skin Conditions: Must have moderate to severe plaque-type psoriasis. Name of Medication Being Tested: Etanercept (Enbrel ®) Criteria Needed to be Entered into Study: Children 4 to 17 years of age Must have psoriasis for minimum of 6 months Minimum 10% of total body surface area of psoriasis Must have ...

Phase N/A

0.36 miles

Learn More »